CME: Nephrotic Syndrome in Adults: Presentation, Diagnosis, Therapy

CME: Nephrotic Syndrome in Adults: Presentation, Diagnosis, Therapy Abstract. The nephrotic syndrome is defined by renal protein loss with hypalbuminaemia and edema. Hyperlipoproteinemia and thrombophilia are not diagnostic criteria, but are frequently associated conditions. Patients with nephrotic...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Praxis (Bern. 1994) 2019, Vol.108 (5), p.347-355
Hauptverfasser: Rieder, Simone C, Huber, Lars C, Trachsler, Johannes, Herberger, Elisabeth
Format: Artikel
Sprache:ger
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 355
container_issue 5
container_start_page 347
container_title Praxis (Bern. 1994)
container_volume 108
creator Rieder, Simone C
Huber, Lars C
Trachsler, Johannes
Herberger, Elisabeth
description CME: Nephrotic Syndrome in Adults: Presentation, Diagnosis, Therapy Abstract. The nephrotic syndrome is defined by renal protein loss with hypalbuminaemia and edema. Hyperlipoproteinemia and thrombophilia are not diagnostic criteria, but are frequently associated conditions. Patients with nephrotic syndrome are at higher risk for infections. Primary causes of a nephrotic syndrome are differentiated from secondary glomerulopathies due to systemic diseases. To confirm the diagnosis and for prognostic reasons, a kidney biopsy is performed in most cases. Steroids and other immunosuppressive agents are frontline therapies in primary forms. Secondary forms are treated by addressing the underlying disease. Therapeutic cornerstones include an adequate RAAS blockade with ACE inhibitors or AT-II receptor blockers. Loop diuretics are used to control edemas. In addition, the need for anticoagulation and statin therapy must be evaluated.
doi_str_mv 10.1024/1661-8157/a003223
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2202663501</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2202663501</sourcerecordid><originalsourceid>FETCH-LOGICAL-p566-a942a083d90fe980f230cb8189a229bba44cbe142b36de0fc0607494d66e4fab3</originalsourceid><addsrcrecordid>eNo9z0lPwzAUBGAfQLQUfgAX5COHhj4vcePeqrQsUlkkeo_s5IUaZcNODvn3VKJwGmn0aaQh5IbBPQMuF0wpFiUsXi4MgOBcnJHpfzchlyF8ASipeXxBJgK0PCo1JWn6sl3RV-wOvu1dTj_GpvBtjdQ1dF0MVR9W9N1jwKY3vWubOd0489m0wYU53R_Qm268IuelqQJen3JG9g_bffoU7d4en9P1LupipSKjJTeQiEJDiTqBkgvIbcISbTjX1hopc4tMcitUgVDmoGAptSyUQlkaK2bk7ne28-33gKHPahdyrCrTYDuEjHPgSokY2JHenuhgayyyzrva-DH7-y1-ACJeVuo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2202663501</pqid></control><display><type>article</type><title>CME: Nephrotic Syndrome in Adults: Presentation, Diagnosis, Therapy</title><source>Hogrefe eContent</source><creator>Rieder, Simone C ; Huber, Lars C ; Trachsler, Johannes ; Herberger, Elisabeth</creator><creatorcontrib>Rieder, Simone C ; Huber, Lars C ; Trachsler, Johannes ; Herberger, Elisabeth</creatorcontrib><description>CME: Nephrotic Syndrome in Adults: Presentation, Diagnosis, Therapy Abstract. The nephrotic syndrome is defined by renal protein loss with hypalbuminaemia and edema. Hyperlipoproteinemia and thrombophilia are not diagnostic criteria, but are frequently associated conditions. Patients with nephrotic syndrome are at higher risk for infections. Primary causes of a nephrotic syndrome are differentiated from secondary glomerulopathies due to systemic diseases. To confirm the diagnosis and for prognostic reasons, a kidney biopsy is performed in most cases. Steroids and other immunosuppressive agents are frontline therapies in primary forms. Secondary forms are treated by addressing the underlying disease. Therapeutic cornerstones include an adequate RAAS blockade with ACE inhibitors or AT-II receptor blockers. Loop diuretics are used to control edemas. In addition, the need for anticoagulation and statin therapy must be evaluated.</description><identifier>ISSN: 1661-8157</identifier><identifier>DOI: 10.1024/1661-8157/a003223</identifier><identifier>PMID: 30940036</identifier><language>ger</language><publisher>Switzerland</publisher><ispartof>Praxis (Bern. 1994), 2019, Vol.108 (5), p.347-355</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4009,27902,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30940036$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rieder, Simone C</creatorcontrib><creatorcontrib>Huber, Lars C</creatorcontrib><creatorcontrib>Trachsler, Johannes</creatorcontrib><creatorcontrib>Herberger, Elisabeth</creatorcontrib><title>CME: Nephrotic Syndrome in Adults: Presentation, Diagnosis, Therapy</title><title>Praxis (Bern. 1994)</title><addtitle>Praxis (Bern 1994)</addtitle><description>CME: Nephrotic Syndrome in Adults: Presentation, Diagnosis, Therapy Abstract. The nephrotic syndrome is defined by renal protein loss with hypalbuminaemia and edema. Hyperlipoproteinemia and thrombophilia are not diagnostic criteria, but are frequently associated conditions. Patients with nephrotic syndrome are at higher risk for infections. Primary causes of a nephrotic syndrome are differentiated from secondary glomerulopathies due to systemic diseases. To confirm the diagnosis and for prognostic reasons, a kidney biopsy is performed in most cases. Steroids and other immunosuppressive agents are frontline therapies in primary forms. Secondary forms are treated by addressing the underlying disease. Therapeutic cornerstones include an adequate RAAS blockade with ACE inhibitors or AT-II receptor blockers. Loop diuretics are used to control edemas. In addition, the need for anticoagulation and statin therapy must be evaluated.</description><issn>1661-8157</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNo9z0lPwzAUBGAfQLQUfgAX5COHhj4vcePeqrQsUlkkeo_s5IUaZcNODvn3VKJwGmn0aaQh5IbBPQMuF0wpFiUsXi4MgOBcnJHpfzchlyF8ASipeXxBJgK0PCo1JWn6sl3RV-wOvu1dTj_GpvBtjdQ1dF0MVR9W9N1jwKY3vWubOd0489m0wYU53R_Qm268IuelqQJen3JG9g_bffoU7d4en9P1LupipSKjJTeQiEJDiTqBkgvIbcISbTjX1hopc4tMcitUgVDmoGAptSyUQlkaK2bk7ne28-33gKHPahdyrCrTYDuEjHPgSokY2JHenuhgayyyzrva-DH7-y1-ACJeVuo</recordid><startdate>2019</startdate><enddate>2019</enddate><creator>Rieder, Simone C</creator><creator>Huber, Lars C</creator><creator>Trachsler, Johannes</creator><creator>Herberger, Elisabeth</creator><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>2019</creationdate><title>CME: Nephrotic Syndrome in Adults: Presentation, Diagnosis, Therapy</title><author>Rieder, Simone C ; Huber, Lars C ; Trachsler, Johannes ; Herberger, Elisabeth</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p566-a942a083d90fe980f230cb8189a229bba44cbe142b36de0fc0607494d66e4fab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>ger</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rieder, Simone C</creatorcontrib><creatorcontrib>Huber, Lars C</creatorcontrib><creatorcontrib>Trachsler, Johannes</creatorcontrib><creatorcontrib>Herberger, Elisabeth</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Praxis (Bern. 1994)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rieder, Simone C</au><au>Huber, Lars C</au><au>Trachsler, Johannes</au><au>Herberger, Elisabeth</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CME: Nephrotic Syndrome in Adults: Presentation, Diagnosis, Therapy</atitle><jtitle>Praxis (Bern. 1994)</jtitle><addtitle>Praxis (Bern 1994)</addtitle><date>2019</date><risdate>2019</risdate><volume>108</volume><issue>5</issue><spage>347</spage><epage>355</epage><pages>347-355</pages><issn>1661-8157</issn><abstract>CME: Nephrotic Syndrome in Adults: Presentation, Diagnosis, Therapy Abstract. The nephrotic syndrome is defined by renal protein loss with hypalbuminaemia and edema. Hyperlipoproteinemia and thrombophilia are not diagnostic criteria, but are frequently associated conditions. Patients with nephrotic syndrome are at higher risk for infections. Primary causes of a nephrotic syndrome are differentiated from secondary glomerulopathies due to systemic diseases. To confirm the diagnosis and for prognostic reasons, a kidney biopsy is performed in most cases. Steroids and other immunosuppressive agents are frontline therapies in primary forms. Secondary forms are treated by addressing the underlying disease. Therapeutic cornerstones include an adequate RAAS blockade with ACE inhibitors or AT-II receptor blockers. Loop diuretics are used to control edemas. In addition, the need for anticoagulation and statin therapy must be evaluated.</abstract><cop>Switzerland</cop><pmid>30940036</pmid><doi>10.1024/1661-8157/a003223</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1661-8157
ispartof Praxis (Bern. 1994), 2019, Vol.108 (5), p.347-355
issn 1661-8157
language ger
recordid cdi_proquest_miscellaneous_2202663501
source Hogrefe eContent
title CME: Nephrotic Syndrome in Adults: Presentation, Diagnosis, Therapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T04%3A17%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CME:%20Nephrotic%20Syndrome%20in%20Adults:%20Presentation,%20Diagnosis,%20Therapy&rft.jtitle=Praxis%20(Bern.%201994)&rft.au=Rieder,%20Simone%20C&rft.date=2019&rft.volume=108&rft.issue=5&rft.spage=347&rft.epage=355&rft.pages=347-355&rft.issn=1661-8157&rft_id=info:doi/10.1024/1661-8157/a003223&rft_dat=%3Cproquest_pubme%3E2202663501%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2202663501&rft_id=info:pmid/30940036&rfr_iscdi=true